Innovative drug discovery and development have revolutionized cancer treatment by targeting specific disease mechanisms. Researchers employ cutting-edge technologies such as high-throughput screening, computational modeling, and genomics to identify new drug candidates. Personalized medicine approaches, using genetic profiling, enhance treatment precision by tailoring therapies to individual patient profiles. These advancements accelerate the development of novel compounds and minimize side effects. Collaborative efforts between academia, pharmaceutical companies, and clinical researchers are pivotal in bringing breakthrough therapies to the forefront, transforming cancer care and outcomes.
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States